Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Oct 1;279(Pt 1):23–27. doi: 10.1042/bj2790023

Regulation by forskolin of cyclic AMP phosphodiesterase and protein kinase C activity in LLC-PK1 cells.

R J Anderson 1, R Breckon 1, D Colston 1
PMCID: PMC1151541  PMID: 1718261

Abstract

Forskolin, a naturally occurring activator of adenylate cyclase, inhibits total and high-affinity cyclic AMP phosphodiesterase activity in soluble and particulate fractions of cultured LLC-PK1 renal epithelial cells. The naturally occurring forskolin analogue 1,9-dideoxyforskolin, which does not stimulate adenylate cyclase activity, is a more potent inhibitor of cyclic AMP phosphodiesterase activity than forskolin. To clarify the structural feature of the forskolin molecule responsible for inhibition of cyclic AMP phosphodiesterase activity, the effects of two agents which share structural identity with portions of the forskolin ring were tested. The steroid 5-pregnenolone, but not the hexose alpha-D-galactose, inhibited cyclic AMP phosphodiesterase activity in LLC-PK1 cells. Forskolin and 1,9-dideoxyforskolin both stimulate protein kinase C activity in LLC-PK1 cells. The effect of 1,9-dideoxyforskolin in stimulating LLC-PK1 protein kinase C activity can be attenuated by staurosporine. Both 5-pregnenolone and alpha-D-galactose also stimulate protein kinase C activity in LLC-PK1 cells. 5-Pregnenolone and the phorbol ester phorbol 12-myristate 13-acetate cause translocation of protein kinase C from a soluble to a particulate fraction, while both 1,9-dideoxyforskolin and alpha-D-galactose increase protein kinase C activity in both soluble and particulate fractions. Our results demonstrate that forskolin exerts diverse enzymic effects in cultured LLC-PK1 cells.

Full text

PDF
23

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craven P. A., DeRubertis F. R. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest. 1989 May;83(5):1667–1675. doi: 10.1172/JCI114066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dixon B. S., Breckon R., Burke C., Anderson R. J. Phorbol esters inhibit adenylate cyclase activity in cultured collecting tubular cells. Am J Physiol. 1988 Jan;254(1 Pt 1):C183–C191. doi: 10.1152/ajpcell.1988.254.1.C183. [DOI] [PubMed] [Google Scholar]
  3. Dixon B. S., Breckon R., Fortune J., Sutherland E., Simon F. R., Anderson R. J. Bradykinin activates protein kinase C in cultured cortical collecting tubular cells. Am J Physiol. 1989 Nov;257(5 Pt 2):F808–F817. doi: 10.1152/ajprenal.1989.257.5.F808. [DOI] [PubMed] [Google Scholar]
  4. Dixon B. S., Breckon R., Kaehny M. M., Dillingham M. A., Anderson R. J. Histidine regulation of cyclic AMP metabolism in cultured renal epithelial LLC-PK1 cells. J Biol Chem. 1990 Jan 15;265(2):760–766. [PubMed] [Google Scholar]
  5. Grant P. G., Mannarino A. F., Colman R. W. cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9071–9075. doi: 10.1073/pnas.85.23.9071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ho A. K., Chik C. L., Klein D. C. Forskolin stimulates pinealocyte cGMP accumulation. Dramatic potentiation by an alpha 1-adrenergic----[Ca2+]i mechanism involving protein kinase C. FEBS Lett. 1989 Jun 5;249(2):207–212. doi: 10.1016/0014-5793(89)80625-8. [DOI] [PubMed] [Google Scholar]
  7. Hoshi T., Garber S. S., Aldrich R. W. Effect of forskolin on voltage-gated K+ channels is independent of adenylate cyclase activation. Science. 1988 Jun 17;240(4859):1652–1655. doi: 10.1126/science.2454506. [DOI] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Laurenza A., Sutkowski E. M., Seamon K. B. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci. 1989 Nov;10(11):442–447. doi: 10.1016/S0165-6147(89)80008-2. [DOI] [PubMed] [Google Scholar]
  10. Lavis V. R., Lee D. P., Shenolikar S. Evidence that forskolin binds to the glucose transporter of human erythrocytes. J Biol Chem. 1987 Oct 25;262(30):14571–14575. [PubMed] [Google Scholar]
  11. Lee T. S., MacGregor L. C., Fluharty S. J., King G. L. Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest. 1989 Jan;83(1):90–94. doi: 10.1172/JCI113889. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  12. Lee T. S., Saltsman K. A., Ohashi H., King G. L. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5141–5145. doi: 10.1073/pnas.86.13.5141. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  13. Lindner E., Dohadwalla A. N., Bhattacharya B. K. Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohli: Forskolin. Arzneimittelforschung. 1978;28(2):284–289. [PubMed] [Google Scholar]
  14. Persaud S. J., Jones P. M., Sugden D., Howell S. L. Translocation of protein kinase C in rat islets of Langerhans. Effects of a phorbol ester, carbachol and glucose. FEBS Lett. 1989 Mar 13;245(1-2):80–84. doi: 10.1016/0014-5793(89)80196-6. [DOI] [PubMed] [Google Scholar]
  15. Seamon K. B., Daly J. W. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1986;20:1–150. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES